FBXO39 (F-box protein 39)

2011-08-01  

Identity

HGNC
LOCATION
17p13.1
LOCUSID
ALIAS
CT144,FBOX39,Fbx39

Other Information

Locus ID:

NCBI: 162517
MIM: 609106
HGNC: 28565
Ensembl: ENSG00000177294

Variants:

dbSNP: 162517
ClinVar: 162517
TCGA: ENSG00000177294
COSMIC: FBXO39

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000177294ENST00000321535Q8N4B4
ENSG00000177294ENST00000572251I3L210
ENSG00000177294ENST00000575022I3L1J5

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

References

Pubmed IDYearTitleCitations
343808282022Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer.0
362442472022The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma.1
343808282022Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer.0
362442472022The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma.1
329022382020Aberrant Expression of Cancer-Testis Antigen FBXO39 in Breast Cancer and its Clinical Significance.1
329022382020Aberrant Expression of Cancer-Testis Antigen FBXO39 in Breast Cancer and its Clinical Significance.1
298027002018Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients.0
298027002018Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients.0
243775782014Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.13
243775782014Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.13
213385772011Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.10
213385772011Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.10

Citation

Dessen P

FBXO39 (F-box protein 39)

Atlas Genet Cytogenet Oncol Haematol. 2011-08-01

Online version: http://atlasgeneticsoncology.org/gene/52316/fbxo39